PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous root bark extract significantly reduced blood glucose in alloxan-induced diabetic rats [PMID:27069932].
Root bark extracts demonstrated in vitro antiplasmodial activity against both chloroquine-sensitive and resistant strains of P. falciparum [PMID:20035853].
Pulp juice showed activity against bacteria associated with periodontal diseases and dental caries [PMID:24945400]; stem bark extracts inhibited S. aureus and E. faecium [PMID:32686689].
Seed extracts demonstrated in vitro antiviral activity, attributed to the alkaloid skimmianine [PMID:12789108].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34446188 (2021) — Neurotoxic Zanthoxylum chalybeum root constituents invoke mosquito larval growth retardation through ecdysteroidogenic CYP450s transcriptional perturbations. · Pesticide biochemistry and physiology
- 2.PMID: 36976158 (2023) — Inhibition Kinetics and Theoretical Studies on Zanthoxylum chalybeum Engl. Dual Inhibitors of α-Glucosidase and α-Amylase. · Journal of xenobiotics
- 3.PMID: 37944876 (2024) — Pancreatic beta cell regenerative potential of Zanthoxylum chalybeum Engl. Aqueous stem bark extract. · Journal of ethnopharmacology
- 4.PMID: 32889048 (2020) — α-Amylase and α-glucosidase inhibitors from Zanthoxylum chalybeum Engl. root bark. · Fitoterapia
- 5.PMID: 27019273